Adient Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Adient in the last twelve months. There are currently 2 sell ratings, 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Adient stock.
View analyst ratings for Adient or view top-rated stocks.

Wall Street analysts have given Adient a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Adient wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Adient is scheduled to release its next quarterly earnings announcement on Monday, November 29th 2021.
View our earnings forecast for Adient.

Adient plc (NYSE:ADNT) posted its quarterly earnings results on Wednesday, August, 4th. The company reported ($0.53) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.15 by $0.68. The firm earned $3.24 billion during the quarter, compared to the consensus estimate of $3.34 billion. Adient had a trailing twelve-month return on equity of 18.97% and a net margin of 0.77%. The business's revenue for the quarter was up 99.4% on a year-over-year basis. During the same period in the prior year, the firm posted ($2.78) EPS.
View Adient's earnings history.

Adient's stock was trading at $16.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, ADNT shares have increased by 128.6% and is now trading at $37.61.
View which stocks have been most impacted by COVID-19.

Adient issued an update on its FY 2021 earnings guidance on Thursday, September, 2nd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $14.30 billion-$14.50 billion, compared to the consensus revenue estimate of $14.80 billion.

10 Wall Street analysts have issued twelve-month target prices for Adient's stock. Their forecasts range from $35.00 to $60.00. On average, they anticipate Adient's share price to reach $49.67 in the next twelve months. This suggests a possible upside of 32.1% from the stock's current price.
View analysts' price targets for Adient or view top-rated stocks among Wall Street analysts.

100 employees have rated Adient CEO Douglas G. DelGrosso on Glassdoor.com. Douglas G. DelGrosso has an approval rating of 77% among Adient's employees.

Some companies that are related to Adient include Icahn Enterprises (IEP), Isuzu Motors (ISUZY), BorgWarner (BWA), Lear (LEA), Gentex (GNTX), Autoliv (ALV), Valeo (VLEEY), Luminar Technologies (LAZR), Veoneer (VNE), Allison Transmission (ALSN), LCI Industries (LCII), Dana (DAN), Dorman Products (DORM), Gentherm (THRM) and Visteon (VC).
View all of ADNT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), Exxon Mobil (XOM), Cisco Systems (CSCO), AbbVie (ABBV), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Ford Motor (F) and Johnson & Johnson (JNJ).

Adient trades on the New York Stock Exchange (NYSE) under the ticker symbol "ADNT."

Adient's stock is owned by a number of institutional and retail investors. Top institutional shareholders include FMR LLC (12.56%), BlackRock Inc. (11.28%), Nuveen Asset Management LLC (3.64%), Hotchkis & Wiley Capital Management LLC (3.23%), State Street Corp (3.06%) and Vanguard Group Inc. (3.02%). Company insiders that own Adient stock include Gregory Scott Smith, Jeffrey Stafeil, Jerome J Dorlack and Michel Pierre Rose Berthelin.
View institutional ownership trends for Adient.

ADNT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, BlackRock Inc., Dimensional Fund Advisors LP, JPMorgan Chase & Co., Hotchkis & Wiley Capital Management LLC, Healthcare of Ontario Pension Plan Trust Fund, Prudential Financial Inc., and Barrow Hanley Mewhinney & Strauss LLC. Company insiders that have sold Adient company stock in the last year include Gregory Scott Smith, Jerome J Dorlack, and Michel Pierre Rose Berthelin.
View insider buying and selling activity for Adient or view top insider-selling stocks.

ADNT stock was purchased by a variety of institutional investors in the last quarter, including FMR LLC, Border to Coast Pensions Partnership Ltd, Price T Rowe Associates Inc. MD, Alyeska Investment Group L.P., Nuveen Asset Management LLC, Morgan Stanley, Morgan Stanley, and Parametric Portfolio Associates LLC. Company insiders that have bought Adient stock in the last two years include Gregory Scott Smith, Jeffrey Stafeil, and Jerome J Dorlack.
View insider buying and selling activity for Adient or or view top insider-buying stocks.

Shares of ADNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ADNT stock can currently be purchased for approximately $37.61.

Adient has a market capitalization of $3.54 billion and generates $12.67 billion in revenue each year. The company earns $-547,000,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

Adient employs 77,000 workers across the globe.

The official website for Adient is www.adient.com.

Adient is headquartered at 49200 Halyard Drive, Plymouth MI, 48170.

Adient's mailing address is 49200 Halyard Drive, Plymouth MI, 48170. The company can be reached via phone at 3537342545000 or via email at [email protected]